Immunity, Inflammation and Disease

Share this on social media:

Wiley has launched an open-access, interdisciplinary journal that aims to provide rapid publication of cutting-edge research across the broad field of immunology.

Immunity, Inflammation and Disease, the latest journal to be launched from the Wiley Open Access program, is supported by a number of major societies; British Society for Immunology; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology; and the British Society for Allergy and Clinical Immunology, as well as leading journals in the field, including Allergy (Impact Factor 6.3), European Journal of Immunology (Impact Factor 5.1) and Clinical and Experimental Allergy (Impact Factor 5.0).

All articles in Immunity, Inflammation and Disease will be published open access under the Creative Commons Attribution (CC-BY) licence on Wiley Online Library and deposited in PubMed Central immediately upon publication.

A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organisation that has a Wiley Open Access Account can publish without directly paying any publication charges. The journal is open to submissions now.

Company: